Prolyl-4-hydroxylase 3 maintains β cell glucose metabolism during fatty acid excess in mice
Authors:
- Daniela NasteskaDNDaniela Nasteska
- Federica CuozzoFCFederica Cuozzo
- Katrina ViloriaKVKatrina Viloria
- Elspeth M. JohnsonEJElspeth M. Johnson
- Alpesh ThakkerATAlpesh Thakker
- Rebecca L. WestbrookRWRebecca L. Westbrook
- Jonathan P. BarlowJBJonathan P. Barlow
- Monica HoangMHMonica Hoang
- Jamie W. JosephJJJamie W. Joseph
- Gareth G. LaveryGLGareth G. Lavery
- Ildem AkermanIAIldem Akerman
Open Access
- 23 August 2021
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (16)
Abstract
The α -ketoglutarate–dependent dioxygenase, prolyl-4-hydroxylase 3 (PHD3), is an HIF target that uses molecular oxygen to hydroxylate peptidyl prolyl residues. Although PHD3 has been reported to influence cancer cell metabolism and liver insulin sensitivity, relatively little is known about the effects of this highly conserved enzyme in insulin-secreting β cells in vivo. Here, we show that the deletion of PHD3 specifically in β cells ( β PHD3KO) was associated with impaired glucose homeostasis in mice fed a high-fat diet. In the early stages of dietary fat excess, β PHD3KO islets energetically rewired, leading to defects in the management of pyruvate fate and a shift from glycolysis to increased fatty acid oxidation (FAO). However, under more prolonged metabolic stress, this switch to preferential FAO in β PHD3KO islets was associated with impaired glucose-stimulated ATP/ADP rises, Ca 2+ fluxes, and insulin secretion. Thus, PHD3 might be a pivotal component of the β cell glucose metabolism machinery in mice by suppressing the use of fatty acids as a primary fuel source during the early phases of metabolic stress.Keywords
Funding Information
- Diabetes UK (17/0005681)
- Medical Research Scotland (MR/N00275X/1,MR/S025618/1)
- ERC (715884)
- Cancer Research UK (C42109/A26982,C42109/A24891)
- British Heart Foundation (FS/15/56/31645)
- Wellcome Trust (104612/Z/14/Z).)
This publication has 63 references indexed in Scilit:
- HIF-independent role of prolyl hydroxylases in the cellular response to amino acidsOncogene, 2012
- Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1Cell, 2011
- PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancerBritish Journal of Cancer, 2010
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- Tumor Vasculature Is Regulated by PHD2-Mediated Angiogenesis and Bone Marrow-Derived Cell RecruitmentCancer Cell, 2009
- A genetically encoded fluorescent reporter of ATP:ADP ratioNature Methods, 2009
- Chronic Suppression of Acetyl-CoA Carboxylase 1 in β-Cells Impairs Insulin Secretion via Inhibition of Glucose Rather Than Lipid MetabolismJournal of Biological Chemistry, 2008
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase PathwayMolecular Cell, 2008
- The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressorGenes & Development, 2008
- The role of rapid lipogenesis in insulin secretion: Insulin secretagogues acutely alter lipid composition of INS-1 832/13 cellsArchives of Biochemistry and Biophysics, 2008